1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
IL1RAP antibodies block IL-1-induced expansion of candidate CML stem cells and mediate cell killing in xenograft models
Ågerstam, Helena LU ; Hansen, Nils LU ; von Palffy, Sofia LU ; Sandén, Carl LU ; Reckzeh, Kristian LU ; Karlsson, Christine LU ; Lilljebjörn, Henrik LU
; Landberg, Niklas
LU
; Askmyr, Maria
LU
and Högberg, Carl
LU
, et al.
(2016)
In Blood
128(23).
p.2683-2693
- Contribution to journal › Article
- 2010
-
Mark
SMAD4 Sequestrates HOXA9 to Protect Hematopoietic Stem Cells Against Leukemia Transformation
(2010) 52nd Annual Meeting of the American-Society-of-Hematology (ASH) In Blood 116(21). p.1297-1298
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
SMAD4 as a therapeutic target in hoxa9-related leukemia
(2009) 38th Annual Scientific Meeting of the ISEH-Society-for-Hematology-and-Stem-Cells In Experimental Hematology 37(9). p.44-45
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.
Quere, Ronan LU ; Karlsson, Göran LU ; Andradottir, Silja LU ; Rissler, Marianne LU ; Olsson, Karin LU ; Hertwig, Falk LU ; Reckzeh, Kristian LU ; Cammenga, Jörg LU and Karlsson, Stefan LU
(2008)
50th Annual Meeting of the American- Society-of-Hematology
In Blood
112(11).
p.635-635
- Contribution to journal › Published meeting abstract